Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY: KVUE )

21.72 +0.16 (+0.74%)
Official Closing Price Updated: 7:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,970,297
Open 21.50
Bid (Size) 21.50 (5)
Ask (Size) 21.75 (7)
Prev. Close 21.56
Today's Range 21.44 - 21.77
52wk Range 17.67 - 24.46
Shares Outstanding N/A
Dividend Yield 3.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now
Via The Motley Fool
Peering Into Kenvue's Recent Short Interest
Via Benzinga

Performance

YTD
+0.70%
+0.70%
1 Month
-10.40%
-10.40%
3 Month
-5.57%
-5.57%
6 Month
+16.84%
+16.84%
1 Year
+2.02%
+2.02%

More News

Read More
Critical Insights From Kenvue Analyst Ratings: What You Need To Know
Via Benzinga
Coca-Cola cs. Procter & Gamble: Which Is the Better Dow Dividend King Stock to Buy Before the End of the Year?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months.
Via The Motley Fool
How Is The Market Feeling About Kenvue?
Via Benzinga
In-Depth Technical Analysis of KENVUE INC.
Via Chartmill
Is Kenvue Stock a Buy Now?
Via The Motley Fool
10 Analysts Have This To Say About Kenvue
Via Benzinga
Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
From Kenvue
Via Business Wire
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
Via Benzinga
Exposures Product Safety
Kenvue (KVUE) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales
Via Benzinga
Kenvue Reports Third Quarter 2024 Results
From Kenvue
Via Business Wire
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
From Kenvue
Via Business Wire
This Big New Development Could Be Bullish for Kenvue Stock
Via The Motley Fool
3 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy.
Via The Motley Fool
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months
Via The Motley Fool
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
Via Investor's Business Daily
Nvidia Among Five Best S&P 500 Stocks Today
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Dow Drops 320 Points as Stocks Cool Off
Via Talk Markets
Topics Stocks
Exposures US Equities
What's Going On With Kenvue Stock Monday?
Via Benzinga
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
Via Benzinga
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.